Hemangiosarcoma is the most common cancer that causes anemia in dogs, but lymphoma, mast cell tumors, and multiple myeloma can all drive red blood cell counts dangerously low. Each cancer type causes anemia through a different mechanism, and understanding which one is involved helps explain what your dog is experiencing and what to expect next.
Hemangiosarcoma: The Leading Cause
Hemangiosarcoma is a malignant tumor of blood vessel cells that most often grows on the spleen, heart, or liver. Because the tumor is essentially a fragile mass of abnormal blood vessels, it bleeds easily and sometimes ruptures without warning. In one study of anemic dogs with a splenic mass and internal bleeding, 70% had hemangiosarcoma, making it by far the most common diagnosis in that group. Of all the malignant splenic tumors identified, 93% were hemangiosarcoma specifically.
The anemia it causes is acute and dramatic. When a splenic tumor ruptures, blood pools freely in the abdomen. Two-thirds of dogs with splenic hemangiosarcoma in one multicenter study had blood in their abdomen at the time of diagnosis. The average hematocrit (the percentage of blood made up of red blood cells) in those dogs was around 30%, compared to a normal range of roughly 37% to 55%. Many dogs present with values far lower, sometimes in the mid-teens, which is life-threatening. Because the red blood cells are being lost through hemorrhage rather than destroyed or suppressed, the bone marrow is actively trying to replace them. This is called regenerative anemia, and a blood test will show immature red blood cells flooding the circulation as the body scrambles to compensate.
Dogs with a ruptured splenic mass often collapse suddenly, have pale gums, a rapid heart rate, and a distended belly. Some dogs experience smaller “micro-bleeds” that seal off on their own, causing episodes of weakness that seem to resolve before the next bleed happens.
Lymphoma and Bone Marrow Crowding
Lymphoma is one of the most frequently diagnosed cancers in dogs, and anemia at the time of diagnosis carries serious prognostic weight. Dogs with lymphoma who are anemic at their first visit have significantly shorter survival times than those with normal red blood cell counts.
Lymphoma causes anemia through several overlapping routes. The most direct is bone marrow infiltration: when lymphoma cells invade the marrow, they physically crowd out the cells responsible for producing red blood cells, white blood cells, and platelets. When more than 50% of the marrow space is taken over by cancer cells, the result is a condition called myelophthisis. The marrow simply can’t manufacture enough healthy blood cells, and counts drop across the board. This type of anemia is non-regenerative, meaning the body isn’t producing new red blood cells to compensate, because the factory itself is compromised.
Lymphoma also triggers chronic inflammation throughout the body. Inflammatory signals alter how iron is stored and transported, effectively locking iron away from the bone marrow even when the body’s total iron stores are adequate. The result is that red blood cells are produced more slowly and may be smaller than normal. This “anemia of chronic disease” can develop alongside marrow infiltration, compounding the problem.
Mast Cell Tumors and GI Bleeding
Mast cell tumors are among the most common skin cancers in dogs, and roughly half of affected dogs develop secondary symptoms from the chemicals these tumor cells release. Mast cells are packed with histamine, and when they degranulate (burst open and release their contents), they flood the bloodstream with it.
That histamine surge stimulates acid-producing cells in the stomach lining, leading to excessive gastric acid. At the same time, histamine damages the walls of small blood vessels and triggers clotting problems that cause localized tissue death in the stomach lining. The combined effect is severe stomach and duodenal ulceration. Dogs with GI ulcers from mast cell tumors may vomit blood, pass dark tarry stools, or develop chronic low-grade bleeding that leads to iron deficiency anemia over time. In serious cases, an ulcer can perforate the intestinal wall entirely, causing peritonitis and sepsis.
Unlike the sudden collapse seen with hemangiosarcoma, anemia from mast cell tumors tends to develop gradually. You might notice your dog becoming progressively more lethargic, losing interest in food, or producing unusual-looking stool before anyone suspects the skin tumor is causing internal problems.
Multiple Myeloma and Red Blood Cell Suppression
Multiple myeloma is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. These malignant plasma cells accumulate in the bone marrow and disrupt normal blood cell production through both physical crowding and chemical interference.
Research has shown that myeloma cells trigger high levels of a signaling molecule called CCL3 in the bone marrow. Elevated CCL3 actively blocks the process by which stem cells mature into red blood cells. It does this by shutting down key genetic switches that normally guide red blood cell development. In lab studies, blocking CCL3’s activity restored normal red blood cell production, confirming it plays a central role. The same chemical signal also causes the bone lesions that are a hallmark of myeloma, so anemia and bone pain often appear together.
Most stem cells in the marrow of myeloma patients get stuck in a resting state and stop dividing toward the red blood cell lineage. The anemia is non-regenerative and tends to worsen as the disease progresses.
How Vets Distinguish the Type of Anemia
When a dog presents with anemia and a suspected cancer, the first diagnostic fork in the road is whether the anemia is regenerative or non-regenerative. A regenerative anemia, where the bone marrow is actively churning out new red blood cells, points toward blood loss. This is the pattern seen with hemangiosarcoma ruptures and GI bleeding from mast cell tumors. A non-regenerative anemia, where the marrow is failing to respond, suggests the problem is inside the marrow itself: infiltration by lymphoma or myeloma cells, or suppression from chronic inflammation.
Your vet will look at the size and shape of red blood cells, count immature red blood cells in circulation, and may recommend imaging (ultrasound of the abdomen, X-rays of the chest) or a bone marrow biopsy depending on the suspected cancer type. Fluid in the abdomen combined with a visible splenic mass on ultrasound is a classic hemangiosarcoma presentation. Abnormally high protein levels in the blood alongside bone lesions and anemia raise suspicion for myeloma.
When Anemia Becomes an Emergency
Regardless of the cancer type, severe anemia is dangerous on its own. Dogs generally need a blood transfusion when their hematocrit drops below about 15% to 17%, or their hemoglobin falls below roughly 5.8 g/dL. In one study, 83% of transfusions were given to dogs with a hematocrit under 17%. The decision isn’t based on numbers alone; vets also assess how the dog is coping. A dog whose anemia developed slowly may tolerate a lower hematocrit than one who lost blood rapidly, because the body has had time to partially adapt.
Signs that anemia has reached a critical point include extreme lethargy, rapid or labored breathing at rest, a heart rate that stays elevated, and gums that are white or very pale rather than their normal pink. If your dog has a known cancer diagnosis and you notice these signs worsening over hours rather than days, that warrants an urgent veterinary visit.